Call for Abstract

9th Annual Summit on Rare Diseases and Orphan Drugs, will be organized around the theme “Light up Show Your Stripes and Share Your Colours”

Rare diseases 2024 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Rare diseases 2024

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The Genetic endocrine tumors are rare, complex, multi-organ conditions that are dominantly inherited, and manifest throughout nonage and adult life. In recent times the identification of the inheritable causes of inheritable endocrine tumors runs has enabled the preface of prophetic testing, with cases being linked in the preclinical state, and frequently in early nonage.

Structured webbing programmes are in place that should enable the discovery and treatment of excrescences at an early stage. Collaboration by experts in inheritable drug, imaging, biochemistry, surgery and endocrinology is essential to achieve the stylish issues. Still, query persists regarding the optimal timing and system of treatment. Data collected from clinicians and cases will guide the group in the prioritization and design of studies that will help us to address these areas of query.

For Growth 5 sub thematic groups are linked grounded on a different multidisciplinary platoon and different individual and treatment approaches.

A group of imprinting diseases for which care have been well organized:

Prader Willi Syndrome, Silver Russell Syndrome, and Beckwith Wiedemann Syndrome and a group of Growth hormone and IGF- I insensitivity including Laron and Noonan Syndrome, as well as other overgrowth and growth deceleration runs.

Rare conditions, affecting growth, with life-long endocrine and metabolic consequences, include imprinting diseases with common molecular mechanisms( Prader Willi, Silver Russell, Beckwith Wiedemann runs), a group of cases with GH and/ or IGF- I insensitivity and cases with other causes of short elevation or overgrowth. This group of diseases needs a multidisciplinary care, networks of croakers around Europe to propose common molecular opinion strategies, care and clinical trials. Current challenges concentrate on perfecting clinical and molecular opinion, personalised remedy, and unraveling long- term consequences of these clinical runs, thereby proposing better opinion, treatment and information from the antenatal period to majority for the cases and their families.

For Genetic disorders of glucose and insulin homeostasis 3 subthematic groups are defined

  • · Insulin- resistance pattern,
  •  Hyperinsulinism and other forms of hypoglycemia
  • · Rare diabetes mellitus

All guidelines for diseases of insulin and glucose homeostasis recommend education in glucose monitoring, diet and pharmacologic treatment with insulin and/ or other drug during pediatric long- term care. The purpose of our network is to give ultramodern, substantiation- grounded care through a multidisciplinary approach to children and adolescents suffering from a rare form of diabetes, hyperinsulinism or lipodystrophy. These include cases with an exceptional cause of diabetes(e.g. insulin- receptor mutations), cases with oppressively unstable and/ or delicate to treat diabetes(e.g. neonatal diabetes), cases with uncommon comorbidities(e.g. WABB runs).

Rare adrenal diseases comprise those with hormonal oversecretition and/ or overgrowth and those with unhappy low endocrine functionality. While oversecretion and tumor growth frequently requires surgical or targeted medical remedy, cases with adrenal insufficiency are in need of technical care for hormonal relief remedy. In all cases, specialized endocrine individual approaches with birth and dynamic tests are necessary. In numerous cases these are substituted by devoted functional imaging procedures, invasive hormonal analyses and/ or targeted inheritable testing and comforting. In cases of nasty adrenal excrescences specialized multidisciplinary brigades are needed for substantiated remedy opinions.

Rare pituitary diseases are a group of colorful clinical runs with low frequence ( main groups 100- 500 million, specific conditions inheritable diseases less than 1 million) taking multidisciplinary and lifelong care because of the central endocrine function of the pituitary, its position in the vicinity of the optical system and the hypothalamus and the associated pituitary hormone disturbance limit QoL and long- term functional outgrowth depending on the specific underpinning complaint, performing in multisystem morbidity.

We've linked 3 sub thematic groups within the pituitary MTG, grounded on different multidisciplinary platoon and different individual and treatment approaches pituitary adenoma, natural hypopituitarism, acquired hypopituitarism. Within the pituitary network we aim to further characterize moxie by creating subsubnetworks fastening on specific ultra-rare conditions (or diagnostics or interventions) within the sub thematic groups.

A reference network for rare thyroid complaint will allow us in an EU-wide collaboration to systemically characterize the phenotype, the genotype and treatment of these cases, including largely specialized in vitro andex-vivo tests. This won't only give important new information on the natural history and complications of these rare thyroid conditions for cases, their families and croakers, but will also allow operation of new treatment strategies in an transnational, European setting and define and ameliorate transnational guidelines on opinion and treatment.

For Thyroid, a division is made in 3 sub thematic groups

The three thematic groups are grounded on different individual strategies and treatment approaches.

Utmost rare pattern still warrant authorized treatments despite major advances in disquisition and furnishing the tools to understand their molecular base. Remedial modalities for restating advances in rare complaint knowledge into implicit medicines are known as orphan drugs. With this in mind, also are the advance antidotes, including small molecules, monoclonal antibodies, protein relief antidotes, oligonucleotides and gene and cell antidotes, as well as drug repurposing. For each system, we consider its strengths and manacle as a platform for rare complaint remedy expansion and describe clinical progress so far in developing drugs predicated on it. We also bat named overarching pattern in the expansion of antidotes for rare conditions, analogous as engagement of cases in the process and digital tools.

Immunological diseases are conditions caused by a dysfunction of the vulnerable system and include antipathetic, asthma, autoimmune ailment and immunological insufficiency. Leukocytes are the cells of the vulnerable system. They're made in one of your lymph organs, the bone gist and it's also called as primary accessible insufficiency. If you get that complaint it'll weakens your vulnerable system. This is called acquired vulnerable insufficiency and having an endangered system which is too active causes antipathetic response having an endangered system that turns against you is called autoimmune complaint.

Calcium and Phosphate Homeostasis is of major significance to a large number of hysiological processes thereby affecting several organ systems generally bone, muscles, order, brain with consequences on quality of life and threat of habitual disability.

These conditions frequently manifest with unspecific symptoms (like seizure, failure to thrive) leading to a severe detention in opinion. For several of these conditions, treatment options are available (or under development) if cases are diagnosed. Still, it's only lately that long- term consequences and burden of the conditions have been characterized.

Establishing databases on these rare conditions is pivotal. For calcium (Ca) and phosphate (Pi), 3 sub thematic groups are linked grounded on the pathophysiology of the conditions, the multidisciplinary care involved and long- term consequences as well as the different exploration approaches. The PTH dependent ambience covers complicated cases of hyperparathyroid hypercalcemia which cannot be treated by simple parathyroidectomy and inheritable runs prepping to hyperparathyroidism. Hypocalcemia enfold hypoparathyroidism, autosomal dominant hypocalcemia as well as vitamin D dependent richets (VDDR). Indisposition of phosphate imbalance share divergent bone and teeth structure, as well as a dysregulation of the FGF23 endocrine system.

An autoimmune complaint is a condition in which the body's vulnerable system miscalculates its own healthy apkins and attacks them. The highest autoimmune complaint causes inflammation that can affect many lobbies of the body. Asherson's model is a rare autoimmune disease. An autoimmune condition is caused when the body's brain's defenses (antibodies, lymphocytes, etc.)Who will get in trouble for?

Autoimmune diseases? Millions of Americans of all ages have autoimmune diseases. Mostly women develop a variety of autoimmune diseases much more often than men. And if you have an autoimmune complaint, you're more likely to have another.

As a result, orphan drugs aimed at dealing with the atmosphere are rare and hesitant to develop them under normal marketing conditions. The process from discovering a new patch to marketing it is a long (10x on average), precious (several million euros) and truly uncertain. Developing a drug to treat a rare condition does not pay off. Orphan drugs are defined as drugs that are not developed by for-profit pharmaceutical technology but that meet the health needs of society. Indeed, drug proposals can also be considered orphaned because one substance may be used to treat a common condition but may not have been developed for another even rarer proposition. Orphan drugs are drugs used to comment, handcuff or treat serious or genuinely voluntary or rare diseases.

An infectious disease can be defined as a syndrome caused by a pathogen or its noxious product, which is the result of transmission from an infected person, infected animal or inanimate object. Contaminating the susceptible host. An infectious disease, also known as an infectious disease, or an infectious disease, is a disease caused by the infection, presence, and growth of pathogenic (potentially pathogenic) biological agents in humans or a specific host. Body. Bubonic and pneumonic plagues are the most notorious infectious diseases.

Infectious diseases: